Matthew Strobeck

CIK 1377832 · last filed 2026-06-02

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$40.81M

Companies

5

Total Filings

88

Lifetime Open-Market Net

$11.83M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
QDEL Director 51,234 $14.13 $723.9K $1.52M 21 2026-06-02
BDSX Director 2,661,931 $15.06 $40.09M $6.89M 18 2026-01-06
Accelerate Diagnostics, Inc (AXDX) Delisted Director 323,238 $0.03 $11.0K $2.67M 24 2024-01-25
YIELD10 BIOSCIENCE, INC. (MBLX) Delisted Director 66,664 $752.6K 23 2016-01-28
SANTARUS INC (SNTS) Delisted Director $0 1 2012-05-16

Recent Filings · Page 3 of 9

88 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-05-16 QDEL Mixed +1,137 $0 EDGAR
2023-01-05 BDSX Grant (A) $0 EDGAR
2023-01-04 BDSX Grant (A) $0 EDGAR
2022-11-21 BDSX Buy (P) +2,343,477 $2.69M EDGAR
2022-06-08 QDEL Grant (A) $0 EDGAR
2022-06-02 Accelerate Diagnostics, Inc (AXDX) Delisted Grant (A) $0 EDGAR
2022-06-01 Grant (A) +61,308 $0
2022-06-01 QDEL Disp (D) −61,308 $0 EDGAR
2022-05-26 BDSX Grant (A) $0 EDGAR
2022-05-20 QDEL Exer (M) +1,624 $0 EDGAR
Showing 2130 of 88
Page 3 of 9
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.